Pfizer Inc (PFE)

$26.67 -0.13 (-0.49%)
Market Cap 155.29B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.52
Forward PE 9.23
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 38,718,407
Avg Vol 37,891,145
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 10%
Beta 0.43
Analysts Sell
Price Target $29.05

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Apr. 23 at 11:38 PM
$PFE enjoy buying a great company..with a great dividend!
0 · Reply
Willieberich
Willieberich Apr. 23 at 11:33 PM
$PFE may 8th dividend date !! You think that this went down for nothing? Does the same thing on high dividend stocks .I'll buy more tomorrow..
0 · Reply
barnabasreynolds
barnabasreynolds Apr. 23 at 10:57 PM
$AAPL $ABT $CLX $PFE $XPEV
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 23 at 10:31 PM
$SLS $PFE $LLY $ABBV $SLS for the passersby Just the secondary asset - SLS009 is worth $27 Per Share / pardon $24.47 Per Share - right now.
0 · Reply
josegodoy
josegodoy Apr. 23 at 9:57 PM
$PFE thinking $25.35-$25.50 MAX
1 · Reply
stockjusthave
stockjusthave Apr. 23 at 8:55 PM
$PFE yes its solid not going anywhere, from 1998 - 30$ to 2026 27$.
1 · Reply
Willieberich
Willieberich Apr. 23 at 8:48 PM
$PFE this no meme .it's an investment company. It's solid .it's cheap to me ..good luck
1 · Reply
Willieberich
Willieberich Apr. 23 at 8:41 PM
$PFE am I the only 1 that's buying here ? 😀 6900 shares in 2 days I bought..so far this is range bound .consolidation..we are at the low of the channel .good luck people .if I knew it would be down here yesterday I would of waited .but you can't te this.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 23 at 8:14 PM
$PFE - Guys, we’re just like Intel! (In reverse!)
1 · Reply
AFJuvat
AFJuvat Apr. 23 at 7:53 PM
$PFE R.I.P. BOURLA
0 · Reply
Latest News on PFE
Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 1 day ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 1 day ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 2 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 3 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 3 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 7 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 12 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 14 days ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 16 days ago

Why Is Pfizer Stock Dropping Tuesday?

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 21 days ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 22 days ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 22 days ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 24 days ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 4 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 4 weeks ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 4 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 4 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 4 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 4 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 4 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 4 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 5 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 5 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 5 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 6 weeks ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 6 weeks ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 7 weeks ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 7 weeks ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 7 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 7 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 7 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 2 months ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 2 months ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 2 months ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 2 months ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 2 months ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 2 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 2 months ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 2 months ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 2 months ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 2 months ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 months ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 2 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Willieberich
Willieberich Apr. 23 at 11:38 PM
$PFE enjoy buying a great company..with a great dividend!
0 · Reply
Willieberich
Willieberich Apr. 23 at 11:33 PM
$PFE may 8th dividend date !! You think that this went down for nothing? Does the same thing on high dividend stocks .I'll buy more tomorrow..
0 · Reply
barnabasreynolds
barnabasreynolds Apr. 23 at 10:57 PM
$AAPL $ABT $CLX $PFE $XPEV
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 23 at 10:31 PM
$SLS $PFE $LLY $ABBV $SLS for the passersby Just the secondary asset - SLS009 is worth $27 Per Share / pardon $24.47 Per Share - right now.
0 · Reply
josegodoy
josegodoy Apr. 23 at 9:57 PM
$PFE thinking $25.35-$25.50 MAX
1 · Reply
stockjusthave
stockjusthave Apr. 23 at 8:55 PM
$PFE yes its solid not going anywhere, from 1998 - 30$ to 2026 27$.
1 · Reply
Willieberich
Willieberich Apr. 23 at 8:48 PM
$PFE this no meme .it's an investment company. It's solid .it's cheap to me ..good luck
1 · Reply
Willieberich
Willieberich Apr. 23 at 8:41 PM
$PFE am I the only 1 that's buying here ? 😀 6900 shares in 2 days I bought..so far this is range bound .consolidation..we are at the low of the channel .good luck people .if I knew it would be down here yesterday I would of waited .but you can't te this.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 23 at 8:14 PM
$PFE - Guys, we’re just like Intel! (In reverse!)
1 · Reply
AFJuvat
AFJuvat Apr. 23 at 7:53 PM
$PFE R.I.P. BOURLA
0 · Reply
StockProTrader4
StockProTrader4 Apr. 23 at 7:43 PM
$DJT Look below! Dont miss out and have to chase later…. Get in now! Come back and thank me later! 👌🏾 $ABT Beat Earnings at all time low - Already making a move today! $CLX Analysts Signal Buy $PFE Reversal incoming $XPEV Near record Low - Reversal These will be the next runners!💥🔥📈Tag this post!.. 👍🏾
0 · Reply
ItsCarRamRod
ItsCarRamRod Apr. 23 at 7:43 PM
$PFE hey looks PFE hitting a 2 month low while the market it hitting ATHs.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 23 at 7:24 PM
$PFE Albert poured his heart out for us this morning giving us an upbeat outlook on Pfizers bright future. He even sprinkled in some greek poetry, and this is the thanks he gets?
1 · Reply
StockProTrader4
StockProTrader4 Apr. 23 at 7:15 PM
$CVS See Look BELOW Folks! Dont miss out and have to chase later…. Get in now! Come back and thank me later! 👌🏾 $ABT Beat Earnings at all time low - Already Moving $CLX Analysts Signal Buy $PFE Reversal incoming $XPEV Near record Low - Reversal These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 Apr. 23 at 7:11 PM
$META Look at these stocks below Folks! Dont miss out and have to chase later when they’re running…. Get in now! Come back and thank me later! 👌🏾 $ABT Beat Earnings at all time low $CLX Analysts Signal Buy $PFE Reversal incoming $XPEV Near record Low - Reversal These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 Apr. 23 at 7:10 PM
$QQQ Look BELOW Folks! Dont miss out and have to chase later… Get in now! Come back and thank me later! 🏦 👌🏾 $ABT Beat Earnings at all time low $CLX Analysts Signal Buy $PFE Reversal incoming $XPEV Near record Low - Reversal These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 Apr. 23 at 7:04 PM
$AAPL Look BELOW Folks! Dont miss out and have to chase later!….Get in now! Come back and thank me later! 👌🏾 $ABT Beat Earnings at all time low $CLX Analysts Signal Buy $PFE Reversal incoming $XPEV Near record Low - Reversal These will be the next runners!💥🔥📈Tag this post and 🏦 👍🏾
0 · Reply
Willieberich
Willieberich Apr. 23 at 6:48 PM
$PFE i5s not a meme stock .it's doing exactly what it should do ..I don't like it coming down to 26.50 to much .but it's still respecting it .added 1800 shares today.
0 · Reply
nimii
nimii Apr. 23 at 6:23 PM
$PFE div day may 8th
1 · Reply
AGGELO_MARKO
AGGELO_MARKO Apr. 23 at 6:02 PM
$PFE trading at $26.43 on 18M volume, losing the $27.24 50D MA today. Tape is heavy following the shareholder meeting; will the $21.97 52W low be back in play?
1 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Apr. 23 at 6:00 PM
$PFE sweet - another Anal-cyst with the dingleberry outlook: Rothschild & Co Redburn Adjusts Price Target on Pfizer to $24 From $25, Maintains Neutral Rating MT NEWSWIRES Apr-23-2026 5:44 a.m. ET 05:44 AM EDT, 04/23/2026 (MT Newswires) -- Pfizer (PFE) has an average rating of hold and mean price target of $28.90, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
0 · Reply
AFJuvat
AFJuvat Apr. 23 at 5:57 PM
$PFE POS CEO, POS Company.
0 · Reply